411 related articles for article (PubMed ID: 36932176)
21. Intra-islet glucagon signaling is critical for maintaining glucose homeostasis.
Zhu L; Dattaroy D; Pham J; Wang L; Barella LF; Cui Y; Wilkins KJ; Roth BL; Hochgeschwender U; Matschinsky FM; Kaestner KH; Doliba NM; Wess J
JCI Insight; 2019 Apr; 5(10):. PubMed ID: 31012868
[TBL] [Abstract][Full Text] [Related]
22. Regulation of glucagon secretion in normal and diabetic human islets by γ-hydroxybutyrate and glycine.
Li C; Liu C; Nissim I; Chen J; Chen P; Doliba N; Zhang T; Nissim I; Daikhin Y; Stokes D; Yudkoff M; Bennett MJ; Stanley CA; Matschinsky FM; Naji A
J Biol Chem; 2013 Feb; 288(6):3938-51. PubMed ID: 23266825
[TBL] [Abstract][Full Text] [Related]
23. The α-cell in diabetes mellitus.
Gromada J; Chabosseau P; Rutter GA
Nat Rev Endocrinol; 2018 Dec; 14(12):694-704. PubMed ID: 30310153
[TBL] [Abstract][Full Text] [Related]
24. Glucagon and type 2 diabetes: the return of the alpha cell.
Lund A; Bagger JI; Christensen M; Knop FK; Vilsbøll T
Curr Diab Rep; 2014 Dec; 14(12):555. PubMed ID: 25344790
[TBL] [Abstract][Full Text] [Related]
25. The human α cell in health and disease.
Pettway YD; Saunders DC; Brissova M
J Endocrinol; 2023 Jul; 258(1):. PubMed ID: 37114672
[TBL] [Abstract][Full Text] [Related]
26. Reduced somatostatin signalling leads to hypersecretion of glucagon in mice fed a high-fat diet.
Kellard JA; Rorsman NJG; Hill TG; Armour SL; van de Bunt M; Rorsman P; Knudsen JG; Briant LJB
Mol Metab; 2020 Oct; 40():101021. PubMed ID: 32446876
[TBL] [Abstract][Full Text] [Related]
27. The Liver-α-Cell Axis in Health and in Disease.
Richter MM; Galsgaard KD; Elmelund E; Knop FK; Suppli MP; Holst JJ; Winther-Sørensen M; Kjeldsen SAS; Wewer Albrechtsen NJ
Diabetes; 2022 Sep; 71(9):1852-1861. PubMed ID: 35657688
[TBL] [Abstract][Full Text] [Related]
28. Islet α cells and glucagon--critical regulators of energy homeostasis.
Campbell JE; Drucker DJ
Nat Rev Endocrinol; 2015 Jun; 11(6):329-38. PubMed ID: 25850661
[TBL] [Abstract][Full Text] [Related]
29. The role of GIP in α-cells and glucagon secretion.
El K; Campbell JE
Peptides; 2020 Mar; 125():170213. PubMed ID: 31785304
[TBL] [Abstract][Full Text] [Related]
30. Reestablishment of Glucose Inhibition of Glucagon Secretion in Small Pseudoislets.
Reissaus CA; Piston DW
Diabetes; 2017 Apr; 66(4):960-969. PubMed ID: 28130310
[TBL] [Abstract][Full Text] [Related]
31. Improved glucose regulation in type 2 diabetic patients with DPP-4 inhibitors: focus on alpha and beta cell function and lipid metabolism.
Ahrén B; Foley JE
Diabetologia; 2016 May; 59(5):907-17. PubMed ID: 26894277
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of the malate-aspartate shuttle in mouse pancreatic islets abolishes glucagon secretion without affecting insulin secretion.
Stamenkovic JA; Andersson LE; Adriaenssens AE; Bagge A; Sharoyko VV; Gribble F; Reimann F; Wollheim CB; Mulder H; Spégel P
Biochem J; 2015 May; 468(1):49-63. PubMed ID: 25731850
[TBL] [Abstract][Full Text] [Related]
33. cAMP signalling in insulin and glucagon secretion.
Tengholm A; Gylfe E
Diabetes Obes Metab; 2017 Sep; 19 Suppl 1():42-53. PubMed ID: 28466587
[TBL] [Abstract][Full Text] [Related]
34. Glucose Controls Glucagon Secretion by Regulating Fatty Acid Oxidation in Pancreatic α-Cells.
Armour SL; Frueh A; Chibalina MV; Dou H; Argemi-Muntadas L; Hamilton A; Katzilieris-Petras G; Carmeliet P; Davies B; Moritz T; Eliasson L; Rorsman P; Knudsen JG
Diabetes; 2023 Oct; 72(10):1446-1459. PubMed ID: 37494670
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic alpha cells and glucagon secretion: Novel functions and targets in glucose homeostasis.
Wendt A; Eliasson L
Curr Opin Pharmacol; 2022 Apr; 63():102199. PubMed ID: 35245797
[TBL] [Abstract][Full Text] [Related]
36. Cell Autonomous Dysfunction and Insulin Resistance in Pancreatic α Cells.
Honzawa N; Fujimoto K; Kitamura T
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357734
[TBL] [Abstract][Full Text] [Related]
37. The past, present, and future physiology and pharmacology of glucagon.
Capozzi ME; D'Alessio DA; Campbell JE
Cell Metab; 2022 Nov; 34(11):1654-1674. PubMed ID: 36323234
[TBL] [Abstract][Full Text] [Related]
38. Human islets contain a subpopulation of glucagon-like peptide-1 secreting α cells that is increased in type 2 diabetes.
Campbell SA; Golec DP; Hubert M; Johnson J; Salamon N; Barr A; MacDonald PE; Philippaert K; Light PE
Mol Metab; 2020 Sep; 39():101014. PubMed ID: 32413586
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic alpha cell-selective deletion of Tcf7l2 impairs glucagon secretion and counter-regulatory responses to hypoglycaemia in mice.
da Silva Xavier G; Mondragon A; Mourougavelou V; Cruciani-Guglielmacci C; Denom J; Herrera PL; Magnan C; Rutter GA
Diabetologia; 2017 Jun; 60(6):1043-1050. PubMed ID: 28343277
[TBL] [Abstract][Full Text] [Related]
40. Glucose controls glucagon secretion by directly modulating cAMP in alpha cells.
Yu Q; Shuai H; Ahooghalandari P; Gylfe E; Tengholm A
Diabetologia; 2019 Jul; 62(7):1212-1224. PubMed ID: 30953108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
